Appendix 3H - Notification of cessation of securities Announcement Summary Entity name BCAL DIAGNOSTICS LIMITED Announcement Type New announcement Date of this announcement Friday November 13, 2026 Details of +securities that have ceased Number of ASX +security +securities that The +securities have...
Notification of cessation of securities - BDX
Filed with ASX · · 4 pages · English
Summary by 6ix AI
BCAL Diagnostics Limited has filed a notification regarding the cessation of certain securities. The filing details the expiry of options that have ceased due to their expiration without exercise or conversion. The announcement also outlines the company's issued capital following these changes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Application for quotation of securities - BDX
- GSS - Panel Receives Application
- Change of Director's Interest Notice
- Quarterly Activities/Appendix 4C Cash Flow Report
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
Later from BCAL Diagnostics
- BCAL Expands Breast Cancer Biomarker Program
- Notification regarding unquoted securities - BDX
- BCAL Position on GSS-MAP Merger
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics